Jaime L Rubin

Summary

Affiliation: Health Economics and Outcomes

Publications

  1. ncbi Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic
    Jaime L Rubin
    i3 Innovus, 10 Cabot Road, Suite 304, Medford, MA 02155, USA
    BMC Infect Dis 10:14. 2010
  2. ncbi Budgetary impact of treatment with adjuvant imatinib for 1 year following surgical resection of Kit-positive localized gastrointestinal stromal tumors
    Jaime L Rubin
    Health Outcomes, i3 Innovus, 10 Cabot Road, Medford, MA, USA
    J Manag Care Pharm 16:482-91. 2010
  3. ncbi Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States
    Jaime L Rubin
    i3 Innovus, 10 Cabot Road, Suite 304, Medford, MA 02155 USA
    Vaccine 28:7634-43. 2010
  4. ncbi Economic model of a birth cohort screening program for hepatitis C virus
    Lisa J McGarry
    OptumInsight, Medford, MA 02155, USA
    Hepatology 55:1344-55. 2012

Collaborators

Detail Information

Publications4

  1. ncbi Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic
    Jaime L Rubin
    i3 Innovus, 10 Cabot Road, Suite 304, Medford, MA 02155, USA
    BMC Infect Dis 10:14. 2010
    ..The 2009 novel influenza A (H1N1) outbreak highlights the importance of interventions that may mitigate the impact of a pandemic...
  2. ncbi Budgetary impact of treatment with adjuvant imatinib for 1 year following surgical resection of Kit-positive localized gastrointestinal stromal tumors
    Jaime L Rubin
    Health Outcomes, i3 Innovus, 10 Cabot Road, Medford, MA, USA
    J Manag Care Pharm 16:482-91. 2010
    ..Although adjuvant imatinib has proven effective in clinical trials, it is important to consider the economic impact to health plans of introducing imatinib in accordance with its new labeled indication...
  3. ncbi Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States
    Jaime L Rubin
    i3 Innovus, 10 Cabot Road, Suite 304, Medford, MA 02155 USA
    Vaccine 28:7634-43. 2010
    ..6 billion over a 10-year period. The serotype catch-up program would prevent an additional 12,600 IPD cases and 404,000 pneumonia cases, and save an additional $737 million compared with no catch-up program...
  4. ncbi Economic model of a birth cohort screening program for hepatitis C virus
    Lisa J McGarry
    OptumInsight, Medford, MA 02155, USA
    Hepatology 55:1344-55. 2012
    ..Conclusion: Birth-cohort screening for HCV is likely to provide important health benefits by reducing lifetime cases of advanced liver disease and HCV-related deaths and is cost-effective at conventional willingness-to-pay thresholds...